申请人:Kneller W. Bruce
公开号:US20060154909A1
公开(公告)日:2006-07-13
A composition having modified or derivative of 1,4,6-androstatriene-3,17-dione (“ATD”) will improve the health of mammalian subjects. The improvement of health is achieved with the administration of an effective amount of the at least one modified or derivative of 1,4,6-androstatriene-3,17-dione. Particularly, health is improved for a subject suffering with a gynecomastia, and/or estrogen-dependent cancer. Also, subjects recovering from steroid misuse/abuse with treatment in accordance with the present invention. Other improvements found to occur with an administration of ATD is that growth is enhanced and/or stimulated in developing mammals, recovery is shortened in cases of severe trauma or burns, mood levels are improved, male fertility is improved, and athletic performance is improved by increasing testosterone and lean muscle mass.
一种含有 1,4,6-雄甾三烯-3,17-二酮("ATD")改良剂或衍生物的组合物可改善哺乳动物的健康状况。通过服用有效量的至少一种 1,4,6-雄甾三烯-3,17-二酮的改良物或衍生物,可以改善健康状况。特别是对于患有妇科炎症和/或雌激素依赖性癌症的受试者来说,健康状况会得到改善。此外,根据本发明进行治疗后,滥用类固醇的受试者也能恢复健康。施用 ATD 还能改善其他方面,如促进和/或刺激发育中哺乳动物的生长,缩短严重创伤或烧伤病例的恢复期,改善情绪水平,提高男性生育能力,以及通过增加睾酮和瘦肌肉质量提高运动成绩。